Big Data and Text-mining Technologies Applied for Breast Cancer Medical Data Analysis

NCT ID: NCT02810093

Last Updated: 2016-06-22

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Total Enrollment

10000 participants

Study Classification

OBSERVATIONAL

Study Start Date

2016-05-31

Study Completion Date

2016-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Primary purpose :

To develop a method to automatically extract and structure the information included in numerous medical records from breast cancer patients.

Secondary purpose :

With this procedure we can analyze the content of ten thousand anonymized textual medical records.

This information should enable us to explore many subjects, such as:

* The impact of certain therapeutic procedures
* The characteristics of sub-groups of patients
* Pregnancy associated breast cancers
* Risk factors

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Breast Cancer

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

RETROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Breast cancer patients between 2000 and 2016

Patients treated for a breast cancer between 2000 and 2016 in the Hospital of Strasbourg (France).

retrospective medical records analyze

Intervention Type OTHER

Ten thousand medical records (between years 2000 and 2016) will be analyzed

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

retrospective medical records analyze

Ten thousand medical records (between years 2000 and 2016) will be analyzed

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Majority (age \> 18)
* Malignant breast tumors
* signed informed consent

Exclusion Criteria

* Benign breast pathology
* Patients not initially treated at the Hôpitaux Universitaires de Strasbourg
Minimum Eligible Age

18 Years

Eligible Sex

FEMALE

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Quantmetry

UNKNOWN

Sponsor Role collaborator

University Hospital, Strasbourg, France

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Carole Mathelin, MD

Role: PRINCIPAL_INVESTIGATOR

Strasbourg's University Hospitals

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

University Strasbourg Hospital

Strasbourg, , France

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

France

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Anne Laudamy

Role: CONTACT

+33 3 88 11 66 88

anatta Razafimanantsoa

Role: CONTACT

+ 33 3 88 11 54 14

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Carole Mathelin, MD

Role: primary

03 88 12 78 34

Karl Neuberger

Role: backup

References

Explore related publications, articles, or registry entries linked to this study.

Simoulin A, Thiebaut N, Neuberger K, Ibnouhsein I, Brunel N, Vine R, Bousquet N, Latapy J, Reix N, Moliere S, Lodi M, Mathelin C. From free-text electronic health records to structured cohorts: Onconum, an innovative methodology for real-world data mining in breast cancer. Comput Methods Programs Biomed. 2023 Oct;240:107693. doi: 10.1016/j.cmpb.2023.107693. Epub 2023 Jun 25.

Reference Type DERIVED
PMID: 37453367 (View on PubMed)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

6373

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Locoregional Recurrence of Breast Cancer
NCT05988112 NOT_YET_RECRUITING